Form 4: Kestra Medical Technologies Director Sells Shares
Insider Transaction (Form 4)
Jeffrey Lawrence Schwartz, a Director and 10% owner of Kestra Medical Technologies, Ltd., sold 3,890 shares of common stock on September 8, 2026 for $25.18 per share.
Summary
- Open-market sale: disposed of 3,890 Common Shares at $25.18 ($97,942) on September 8, 2026; holds 7,019 after (Direct).
- Grant/award: acquired 7,217 Common Shares on September 9, 2026; holds 14,236 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $97,942 of stock on the open market.
Insider Transactions
Jeffrey Lawrence Schwartz — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Open-market sale | Common Shares | 3,890 | $25 | $97.9K | 7,019 |
| 2026-09-09 | Grant/award | Common Shares | 7,217 | — | — | 14,236 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Open-market sale (3,890 shares) |
| 2026-09-09 | Grant/award (7,217 shares) |
Keywords
insider transaction, Form 4, KMTS, KESTRA MEDICAL TECHNOLOGIES, LTD., bearish, Jeffrey Lawrence Schwartz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.